Latest News and Press Releases

OXiGENE Reports Positive Interim Results from Phase Ib ZYBRESTAT(TM) - Bevacizumab Combination Study in Advanced Solid Tumors Combination Regimen Appears Safe and Well-Tolerated with Early Evidence...

On October 4, 2007, AB DnB NORD Bankas (company code 112029270, VAT payer code LT120292716, registered office at J. Basanavičiaus St. 26, Vilnius, the data is collected and stored at the Register of...

KARO BIO PRESENTERAR POSITIVA KB2115 FAS IIa DATA PÅ TVÅ STORA VETENSKAPLIGA MÖTEN KB2115 ger en kraftig och kliniskt relevant sänkning av ett antal riskfaktorer för utveckling av hjärt/kärl-sjukdom...

KARO BIO PRESENTS POSITIVE KB2115 PHASE IIa PROOF OF CONCEPT DATA AT TWO MAJOR SCIENTIFIC MEETINGS KB2115 induces a profound and clinically relevant lowering of a number of risk factors for...

Offer of commission-free trading In accordance with the decision taken at the 2007 AGM, Fabege is offering shareholders with holdings that are not evenly divisible by 100 (one round lot) the...

Erbjudande om courtagefri handel I enlighet med beslut på årsstämman 2007 erbjuds aktieägare med aktieinnehav som inte är jämnt delbara med 100 (en börspost) att courtagefritt antingen komplettera...

Sjælsø Gruppen A/S - issue as a consequence of utilization of warrants The share capital of Sjælsø Gruppen A/S will be increased by 351,204 new shares each bearing a face value of DKK 10. The...

The correction concerns the orderbook ID for shares in AB Sagax. On request by AB Sagax OMX Nordic Exchange Stockholm has approved a listing of the company’s ordinary shares and preference shares on...

Korrigeringen avser orderboks ID för aktierna i AB Sagax. På ansökan av AB Sagax beslutar OMX Nordic Exchange Stockholm att bolagets stamaktie och preferensaktie skall noteras på OMX Nordic Exchange...

MIAMI, Oct. 5, 2007 (PRIME NEWSWIRE) -- Aventura Holdings, Inc. (OTCBB:AVNT) (referred to as "Aventura", the "Company", "we", "our" or "us") has received inquiries through our website regarding the...